Phosphorylation of Human Thyroid Hormone Receptor beta-1 by Casein Kinase II
Phosphorylation of Human Thyroid Hormone Receptor beta-1 by Casein Kinase II
批准号:
09671018
负责人:
SUGAWARA Akira
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Bacterially-expressed human thyroid hormone receptor beta-1 (hTRbeta1) recently has been shown to be phosphorylated in vitro by HeLa cytoso1ic extract. In the present study, we first demonstrated that hTRbeta1 also could be phosphorylated in vitro b purified casein kinase II (CKII). Phosphoamino acid analysis revealed hTrbeta1 was phosphorylated on both serine and threonine residues. In vitro CKII phosphorylation of glutathione S-transferase (GST)-hTRbeta1 fusion proteins whose predicted CKII phosphorylation sites were mutated demonstrated that a threonine residue located in the hinge region(Thr-210) could be phosphorylated by CKII. In order to elucidate the functional significance of CKfl phosphorylation of Thr-210 in hTRbeta1, we next performed transient transfection studies using either wild type or Thr-210 mutated hTRbeta1.In terestingly, the basal repression eve in the absence of ligand was attenuated significantly when Thr-210 mutated hTRbeta1 was used. Since Thr-210 is located within the interacting domain with nudear receptor co-repressor (N-CoR), we next performed electrophoretic mobility shifi assay (EMSA)to examine the interaction between amino terminal-truncated N-CoR (NCoRI) and wild type or Thr-210 mutated hTRbeta1. Interestingly, in contrast to retinoid OMEGA receptor beta(RXRbeta) which equally formed heterodimers with both types of hTR beta1, N CoRIp referentially formed heterodimers with wild type hTRbeta1 than Thr-210mutated hTRbeta1. Taken together, we speculate that CKII phosphorylation ofThr-210 m hTRbeta1 might modulate interaction with N-Co R, and contribute tomediate basal repression in the absence of ligand.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
菅原 明、他: "ヒトβ1型甲状腺ホルモン受容体 (hTRβ1) のカゼインキナーゼII (CKII) によるリン酸化メカニズムの解明" 診療と新薬. 第36巻第7号 未定. (1999)
Akira Sukawara 等人:“通过酪蛋白激酶 II (CKII) 阐明人 β1 甲状腺激素受体 (hTRβ1) 的磷酸化机制”,《医学实践与新药》第 36 卷,第 7 期,TBA。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
菅原 明、他: "ヒトβ1型甲状腺ホルモン受容体(hTRβ1)のカゼインキナーゼII (CKII)によるリン酸化メカニズムの解明" 診療と新薬. 第36巻 第7号. (1999)
Akira Sukawara 等人:“通过酪蛋白激酶 II (CKII) 阐明人 β1 甲状腺激素受体 (hTRβ1) 的磷酸化机制”,《医学实践与新药》,第 36 卷,第 7 期(1999 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Innovation of a novel anti-hypertensive therapy due to the inhibitionof aldosterone synthase (CYP11B2) gene expression
-
批准号:22591006
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:SUGAWARA Akira
-
依托单位:
EFFECTS OF ALL-TRANS RETINOIC ACID AND RETINOIDS ON ANGIOGENESIS
-
批准号:18591015
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2006
-
负责人:SUGAWARA Akira
-
依托单位:
Effect of co-activator proteins on peroxisome proliferator-activated receptor (PPAR-γ-mediated gene transcription in vascular smooth muscle cells
-
批准号:14571058
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:SUGAWARA Akira
-
依托单位:
Significance and molecular mechanisms of natriuretic peptide family in the protection from renal dysfunction
-
批准号:11671066
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1999
-
负责人:SUGAWARA Akira
-
依托单位:
Joint study for the thyroid hormone receptor phosphorylation
-
批准号:08044231
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$0.64万
-
财政年份:1996
-
负责人:SUGAWARA Akira
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
-
批准号:82371007
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:雷浪
-
依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:傅强
-
依托单位:
丹参酮ⅡA通过靶向TRAIL-receptor和ULBPs增强NK细胞抗非小细胞肺癌效应的作用及分子机制研究
-
批准号:81903932
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:龚陈媛
-
依托单位:
白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究
-
批准号:81970025
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:高金明
-
依托单位:
无脊椎动物新型受体Parathyroid hormone receptor like (PTHRL) 的鉴定及其对赤拟谷盗表皮发育的调控
-
批准号:31872970
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:李斌
-
依托单位:
衰老过程中Lamin-B Receptor蛋白聚积通过扰乱干细胞竞争促进生殖干细胞丢失的分子机制研究
-
批准号:31671254
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2016
-
负责人:陈海洋
-
依托单位:
Leptin Receptor负向调控应力刺激诱导的后纵韧带骨化的分子机制及转化研究
-
批准号:81401821
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:陈剑
-
依托单位:
受体相互作用蛋白3(Receptor-interacting protein 3,RIP3)调控神经元缺血性程序性坏死的作用及机制研究
-
批准号:81271272
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:罗本燕
-
依托单位:
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
-
批准号:31270835
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:张云
-
依托单位:
Retinoid X Receptor(RXR)α启动子甲基化在结直肠癌发生发展中的作用
-
批准号:81201582
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:张芬芬
-
依托单位: